Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Therapeutic and rehabilitation devices / Hospital infusion and drug-delivery pump programmes

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Hospital infusion and drug-delivery pump programmes

Acute-care hospitals and large ambulatory infusion centres buying infusion pumps, syringe pumps, elastomeric and volumetric pumps plus administration sets and consumables for IV, subcutaneous, enteral and chemotherapy delivery in inpatient and outpatient settings.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
80 /100
for B2B sellers
Evidence
not sized
3 sources · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Hospitals (acute-care and infusion centres)
Buying centre
Clinical engineering / nursing infusion therapy leadership with procurement and value-analysis committee; group purchasing organisation (GPO) influence on contract award
Buying triggers
  • Drug and biologic pipeline requiring new delivery modalities (e.g. complex biologics, home oncology)
  • Pump fleet ageing and end-of-support refresh cycles
  • Smart-pump interoperability with the hospital EMR/EHR and barcode medication administration
  • Cost pressure on high-cost consumables and drug waste reduction
Pains
  • Interoperability gaps between pumps and EHR/EMR and medication safety systems
  • High total cost of ownership: capital plus single-use administration sets and maintenance
  • Nurse workflow burden and documentation load
  • Inconsistent utilisation and idle capital across units
Scores (1–5)
Pain intensity4
Purchasing power4
Reachability4
Growth4

How this was sized

Not sized yet

Bottom-up: no source in the set sizes infusion/drug-delivery pumps specifically. Indicative arithmetic only: global medical device market ~USD 580-640bn in 2026 [4]; infusion and drug-delivery devices are commonly estimated at roughly 8-12% of the device market, implying ~USD 50-75bn globally, of which the hospital acute-care share is roughly 60-70% (USD 30-50bn). Low confidence: the segment share is an assumption, not a cited figure, and the sources do not break out pumps or consumables. Sources [4][6][9] used only for the total device market anchor.

Alongside it in Therapeutic and rehabilitation devices

// Sell into Hospital infusion and drug-delivery pump programmes

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.